Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1637 1647 1656
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18389403 | METHODS FOR ASSAYING ENZYME ACTIVITY | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18310921 | METHODS FOR REDUCING LIPASE ACTIVITY | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18175914 | MANUFACTURING PROCESS FOR HIGH TITER ANTIBODY | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18976712 | NOVEL STRAINS AND METHODS FOR THE CONTINUOUS PRODUCTION OF A NUTRITIVE COMPOSITION | Final Rejection | LanzaTech, Inc. |
| 18165620 | METHOD OF PRODUCING HYDROGEN PEROXIDE USING MICROORGANISM OF THE GENUS DESEMZIA | Non-Final OA | Gwangju Institute of Science and Technology |
| 18391959 | ENGINEERED PROTEINS AND METHODS OF USE THEREOF | Non-Final OA | Pairwise Plants Services, Inc. |
| 18516054 | P450-BM3 VARIANTS WITH IMPROVED ACTIVITY | Non-Final OA | Codexis, Inc. |
| 18478179 | METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES | Non-Final OA | Prime Medicine, Inc. |
| 18550967 | FUSION PROTEINS COMPRISING GG REPEAT SEQUENCES | Non-Final OA | Numaferm GmbH |
| 18278778 | METHOD FOR PRODUCING A PERIPLASMIC FORM OF THE PROTEIN CRM197 | Non-Final OA | CURAVAC EUROPE |
| 17774215 | METHODS FOR DISTINGUISHING THE STAGES OF BACTERIAL VAGINOSIS | Final Rejection | University Of Maryland, Baltimore |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy